PDS Biotech adds NantWorks founder Patrick Soon-Shiong to board under PIPE deal
PDSB•Board appointment under PIPE deal
PDS Biotech added Dr. Patrick Soon-Shiong to its board under a PIPE led by Nant Capital.
- Soon-Shiong is a physician-scientist, biotech entrepreneur, investor, and former developer of an FDA-approved immunocytokine.
- Nant can designate a second director while it owns at least 15% of outstanding common stock, subject to a 19.9% cap.
